DRC Systems India Ltd Forensic Report - SOIC x StockScans Report

as of Aug 2026

DRC Systems India Ltd's audited record is clean on its face: six consecutive years of unqualified opinions, no regulator actions, and no fraud reported. But the profit that carries that clean opinion is concentrated in subsidiaries audited by other firms, related-party transactions have repeatedly exceeded 10% of turnover after the company initially denied the relationship, and promoter remuneration is rising 50% despite the company's own statement of "inadequate profits."

Key findings

  1. Related-party transactions repeatedly exceeded 10% of turnover after the company denied the relationship Major - For FY2023-24, the company sought shareholder ratification of transactions with AppiZap LLC FZ (₹16.58 crore, 64.72% of FY2022-23 consolidated turnover) and Infibeam Avenues Limited (₹14.98 crore, 58.44%), while stating it believed these parties were NOT related parties. Shareholders later approved AppiZap transactions up to ₹20 crore at the 13th AGM on September 25, 2025, with 99.9994% votes in favour.
  2. Promoter-MD remuneration rises 50% despite "inadequate profits"; ESOPs granted 93-98% below market Major - Mr. Hiten Barchha's proposed MD remuneration rises from ₹1.00 crore to ₹1.50 crore per annum for the term starting November 09, 2026, with the company stating it has "inadequate profits" and that the remuneration "exceeds the limit prescribed under Schedule V". The ESOP scheme has an exercise price of Re 1 per share, 93% to 98% below market price at grant date, disclosed in every annual report from FY2020-21 through FY2025-26.
  3. Profit recognition shaped by fair-value gains, capitalised ESOP costs, and a prior-period restatement Major - A fair-value gain on an investment drove Other Income from ₹33.09 lakhs in FY2021-22 to ₹4.23 crore in FY2022-23. The company capitalised ESOP cost of ₹2.75 crore into intangible assets under development in FY2022-23, and its Statement of Changes in Equity references "Changes in Equity Share capital due to prior period errors" with restated balances.
  4. Unsatisfied performance obligations peaked at ₹22.37 crore in FY2025, then declined Minor - Consolidated remaining performance obligations rose from ₹5.09 Lakhs as of March 31, 2023 to ₹22.37 crore as of March 31, 2025, then declined to ₹17.98 crore as of March 31, 2026. Standalone obligations were ₹36.85 Lakhs as of March 31, 2025 and ₹11.2 crore as of March 31, 2026.
  5. "Zero debt" rests on a narrow definition while fixed deposits under lien grow Minor - The company reported NIL total financial indebtedness as of 07-02-2025. Fixed deposits under lien from banks grew from Rs. 3.71 Lakhs at March 31, 2022 to Rs. 42.68 Lakhs at March 31, 2026, and the group holds perpetual securities with no fixed maturity date, redeemable only at the issuer's option.
  6. Same audit firm held continuously since 2017 with no change or regulatory action Minor - Rajpara Associates was appointed at the 5th AGM held September 20, 2017 and re-appointed at the 10th AGM held June 29, 2022 for a second five-year term. The CARO report for FY2024-25 states there was no resignation of statutory auditors during the year.
  7. No regulator actions or penalties across six years, one settled promoter trading lapse Minor - The company reported "NIL" for non-compliance or penalties imposed by Stock Exchanges, SEBI, or any statutory authority in each annual report from FY2021 through FY2026. In FY2022, a promoter purchased a small quantity of shares in contravention of insider trading regulations; the company imposed a penalty and issued a caution notice.

What to watch

Bottom line: This is a disclosed, audited record with a clean opinion history and no regulator actions. The risk sits in the gap between the listed entity and its reported profit: most earnings come from subsidiaries audited by other firms, related-party transactions have repeatedly crossed 10% of turnover after initial denials, and promoter pay is rising despite the company's own "inadequate profits" statement. Watch the shareholder vote on remuneration and whether the approved AppiZap limits and performance obligations convert as disclosed.